In the previous trading session, investors closely monitored quarterly earnings announcements, corporate developments and strategic business updates across multiple sectors.
Market participants are expected to track company-specific triggers, including earnings performance, acquisitions, regulatory approvals, order wins and promoter transactions that could influence stock-specific activity during today’s trade.
InterGlobe Aviation reported a consolidated net loss of ₹2,536.9 crore in the fourth quarter compared with a profit of ₹3,067.5 crore in the corresponding period last year. Revenue increased marginally by 1.3% year-on-year to ₹22,438.4 crore, while EBITDAR declined 67.9% to ₹2,227.8 crore. The EBITDAR margin also contracted sharply to 9.9% from 31.4% a year earlier.
Concord Biotech posted a decline in quarterly performance, with consolidated net profit falling 36.8% year-on-year to ₹88.8 crore. Revenue from operations decreased 24.1% to ₹326.1 crore, making the stock one of the key earnings-driven counters to watch.
NMDC delivered a strong set of quarterly numbers. Consolidated net profit rose 36% year-on-year to ₹2,017.6 crore, while revenue surged 61.9% to ₹11,343.1 crore. The robust growth reflects improved operational performance and strong demand conditions.
Lumax Auto Technologies reported healthy growth during the quarter. Consolidated profit increased 51% year-on-year to ₹88.1 crore, while revenue climbed 25.1% to ₹1,416.9 crore, supported by continued momentum in the automotive components segment.
Olectra Greentech registered strong earnings growth, with consolidated profit jumping 164.4% year-on-year to ₹55.5 crore. Revenue increased 43.6% to ₹644.7 crore, highlighting sustained demand in the electric mobility and green transportation space.
Cyient entered into a definitive agreement to acquire Tao Digital Solutions Inc., an AI-native data and product engineering solutions company headquartered in Santa Clara, California. The acquisition values the business at US$218 million and is expected to be completed by the second quarter of FY27. The transaction is aimed at strengthening Cyient’s digital engineering and artificial intelligence capabilities.
Lupin received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Sodium Sulfate, Magnesium Sulfate and Potassium Chloride tablets. The product is indicated for colon cleansing prior to colonoscopy procedures in adults, further expanding the company’s regulated market portfolio.
PB Fintech remained in focus after founders Yashish Dahiya and Alok Bansal sold shares through block deals. Dahiya sold 26 lakh shares, representing a 0.56% stake, for ₹455.26 crore, while Bansal offloaded 12 lakh shares, equivalent to a 0.26% stake, for ₹210.12 crore. The transactions were executed at ₹1,751 per share and attracted participation from several domestic and global institutional investors.
PNC Infratech secured an EPC work order worth ₹302.44 crore from the Airports Authority of India. The order is expected to strengthen the company’s project pipeline and enhance revenue visibility.
Read More: Infrastructure Projects Worth ₹6.01 Lakh Crore Added in Q4 FY26, Nearly 69% Linked to Highways!
Quarterly earnings announcements, strategic acquisitions, regulatory approvals, infrastructure orders and notable block deals are likely to drive stock-specific action in today’s trading session. Investors will closely monitor these developments for cues on near-term market sentiment and individual stock performance.
Want to track these market movements in Hindi? Visit Angel One News for daily updates and comprehensive share market news in Hindi.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks. Read all related documents carefully before investing.
Published on: Jun 1, 2026, 8:43 AM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
